Most importantly, survival analysis indicates that gastric and esophageal adenocarcinomas with PD-1/PD-L1/CD8 “low” signature is characterized by poor long-term prognosis, as compared with the other two subgroups under investigation (p = 0.015, Figure 2). Here, CD274 is linked to esophageal adenocarcinoma.